Drugs / Immunoglobulin Yolk
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02341352 | Apr 2013 → Apr 2015 | dental caries | Zhejiang University | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Immunoglobulin Yolk | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02341352 ↗ |
| Action | Inhibit | “Aoliding oral bacteriostatic spray(Hangzhou YaSheng Biotech)” NCT02341352 ↗ |
| Modality | Protein / enzyme biologic | “anti-Streptococcus mutans IgY” NCT02341352 ↗ |
| Route | Oral | “oral bacteriostatic spray” NCT02341352 ↗ |